TRBCX | VIGAX | TRBCX / VIGAX | |
Total Expense Ratio | 0.69 | 0.05 | 1,380% |
Annual Report Gross Expense Ratio | 0.69 | 0.05 | 1,380% |
Fund Existence | 32 years | 25 years | - |
Gain YTD | 13.019 | 12.745 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 67.7B | 328B | 21% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 16.66 | 27.21 | 61% |
Returns for 3 years | 72.83 | 96.75 | 75% |
Returns for 5 years | 34.49 | 100.98 | 34% |
Returns for 10 years | 197.80 | 347.46 | 57% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBBQ | 24.21 | 0.41 | +1.72% |
Invesco Nasdaq Biotechnology ETF | |||
AGEM | 35.41 | 0.40 | +1.13% |
abrdn Emerging Markets Dividend Act ETF | |||
BSJP | 23.09 | 0.01 | +0.06% |
Invesco BulletShares 2025 HY Corp Bd ETF | |||
GSLC | 127.29 | -0.32 | -0.25% |
Goldman Sachs ActiveBeta® US LgCp Eq ETF | |||
TBG | 33.28 | -0.11 | -0.33% |
TBG Dividend Focus ETF |